Arctic Bioscience Logo

Arctic Bioscience

Develops pharma & nutra ingredients from marine lipids for autoimmune & wellness applications.

ABS | OL

Overview

Corporate Details

ISIN(s):
NO0010859580
LEI:
549300Z2HW6I989Q2C78
Country:
Norway
Address:
Industrivegen 42, 6155 ØRSTA
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Arctic Bioscience is a biotechnology company that develops, manufactures, and commercializes pharmaceutical and nutraceutical ingredients derived from marine membrane lipids. Leveraging over 30 years of experience, the company utilizes proprietary technology to extract bioactive compounds, such as high-DHA Omega-3 phospholipids, from sustainably sourced Norwegian herring roe. Its business is structured into two main segments: a nutraceutical division, which markets products under the Romega® brand, and a pharmaceutical division focused on developing novel therapies for autoimmune disorders. The company's approach is founded on extensive scientific research and a commitment to sustainable practices.

Social Media

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-11-11 12:04
Regulatory News Service
Arctic Bioscience - Protokoll fra ekstraordinær generalforsamling - Attachment:…
Norwegian 346.3 KB
2025-11-11 12:04
Regulatory News Service
Arctic Bioscience - Minutes of the Extraordinary General Meeting - Attachment: …
Norwegian 346.3 KB
2025-11-11 12:04
Post-Annual General Meeting Information
Arctic Bioscience - Protokoll fra ekstraordinær generalforsamling
Norwegian 1.6 KB
2025-11-11 12:04
Post-Annual General Meeting Information
Arctic Bioscience - Minutes of the Extraordinary General Meeting
English 1.6 KB
2025-11-10 07:00
Investor Presentation
Arctic Bioscience - Q3 2025 Operational update - Significant results on systemi…
English 4.1 MB
2025-11-10 07:00
Investor Presentation
Arctic Bioscience - 3. kvartal 2025 operasjonell oppdatering - Signifikante eff…
English 4.1 MB
2025-11-10 07:00
Earnings Release
Arctic Bioscience - Q3 2025 Operational update - Significant results on systemi…
English 9.8 KB
2025-11-10 07:00
Earnings Release
Arctic Bioscience - 3. kvartal 2025 operasjonell oppdatering - Signifikante eff…
Norwegian 10.0 KB
2025-11-07 08:00
Report Publication Announcement
Arctic Bioscience - Invitation to presentation of Q3 operational update and HeR…
English 2.1 KB
2025-11-07 08:00
Report Publication Announcement
Arctic Bioscience - Invitasjon til presentasjon av Q3 operasjonell oppdatering …
Norwegian 2.1 KB
2025-11-04 08:52
Regulatory News Service
Arctic Bioscience - Analyse av HeROPA-studien viser statistisk signifikante eff…
Norwegian 1.7 MB
2025-11-04 08:52
Regulatory News Service
Arctic Bioscience - Analysis on HeROPA study shows statistically significant ef…
English 1.7 MB
2025-11-04 08:52
Regulatory News Service
Arctic Bioscience - Analyse av HeROPA-studien viser statistisk signifikante eff…
Norwegian 5.3 KB
2025-11-04 08:52
Regulatory News Service
Arctic Bioscience - Analysis on HeROPA study shows statistically significant ef…
English 5.5 KB
2025-10-28 09:30
Pre-Annual General Meeting Information
Arctic Bioscience - Innkalling til ekstraordinær generalforsamling 11. november…
Norwegian 1.1 MB

Automate Your Workflow. Get a real-time feed of all Arctic Bioscience filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Arctic Bioscience

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Arctic Bioscience via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Cabaletta Bio, Inc. Logo
Develops engineered T cell therapies for a curative reset in autoimmune diseases.
United States of America
CABA
Cadrenal Therapeutics, Inc. Logo
Developing novel anticoagulant therapies for high-risk cardiovascular patients.
United States of America
CVKD
CalciMedica, Inc. Logo
Develops CRAC channel inhibitors for critical illnesses like acute pancreatitis & AKI.
United States of America
CALC
Calidi Biotherapeutics, Inc. Logo
Develops immunotherapies using stem cells to deliver oncolytic viruses against solid tumors.
United States of America
CLDI
Calliditas Therapeutics Logo
Develops and commercializes novel treatments for rare renal and hepatic diseases like IgA nephropathy.
Sweden
CALTX
CALTH. Inc Logo
Develops AI-powered rapid diagnostic solutions for point-of-care and self-testing.
South Korea
402420
CAMBRIDGE NUTRITIONAL SCIENCES PLC Logo
Develops and manufactures diagnostic tests for food sensitivity and gut health.
United Kingdom
CNSL
Camp4 Therapeutics Corp Logo
Developing RNA-based therapies to upregulate genes for rare metabolic and CNS disorders.
United States of America
CAMP
Camurus Logo
Develops long-acting medicines for severe chronic diseases using advanced drug delivery.
Sweden
CAMX
Clinical-stage biopharma developing novel cancer drugs aiming for fewer side effects.
Japan
4575

Talk to a Data Expert

Have a question? We'll get back to you promptly.